Skip to main content
All lobbying filings

Abbott Laboratories

Abbott Laboratories filed a Q1 report for Abbott Laboratories on April 20, 2026.

Lobbying for Abbott Laboratories

As filed: ABBOTT LABORATORIES for ABBOTT LABORATORIES.

All filings by Abbott Laboratories · Everything Abbott Laboratories has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$1,410,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 2
  • ASHLI DOUGLAS New on this filing
    Previously held: (Employee of affiliated org. Exact Sciences Corporation.)
  • JESSE SHELBURNE New on this filing
    Previously held: (Employee of affiliated org. Exact Sciences Corporation.)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 10

Proposals to reform domestic and international tax structures.

Proposals related to third party litigation reform.

S. 3387 - Ensuring Safe and Toxic-Free Foods Act of 2023. H.R. 9817 Toxic Free Food Act of 2024. H.R. 4958 The Grocery Reform and Safety (GRAS) Act. Proposals related to heavy metals in food.

Proposals related to pension premiums and employee benefits.

Proposals related to the use of the Uniform Commercial Code (UCC).

Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.

H.R. 7118 The Genomic Answers for Children's Health Act. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals related to the coverage of continuous glucose monitors in TRICARE. Proposals to support updates to the Veteran colorectal cancer screening directive.

S. 2761/H.R. 5269 The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to the implementation of the Medical Device User Fee Amendments. Proposals related to coverage for rare disease testing.

Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula.

 Bills named in this filing 7
  • S. 3387
    Ensuring Safe and Toxic-Free Foods Act of 2023
  • H.R. 9817
    Toxic Free Food Act of 2024
  • H.R. 4958
    GRAS Act
  • H.R. 7118
    Genomic Answers for Children’s Health Act of 2026
  • S. 2761
    RESULTS Act
  • H.R. 5269
    RESULTS Act
  • H.R. 2300
    To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…
 Affiliated organizations 1

Section 6 of the LD-2: organizations that contribute to this lobbying or take an active part in directing it. On a trade association's filing, this is where its backers appear.

  • EXACT SCIENCES CORPORATION
    Madison, Wisconsin

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem